Columns

It’s holiday shopping season. Let's talk retail stocks, we've mentioned  a lot of names since this show began -- and most are higher. Here are my top 8 picks that haven’t popped too much to chase:

Target's CEO abruptly resigned Monday, sending shares of the retailer lower in early trading. 

Advanced Micro Devices shares climbed on Monday on the back of a strong quarterly reports.

SodaStream shares jumped Wednesday on a report it plans on selling a stake to a large soda producer. 

Bank of America shares fell on Monday after the No. 2 U.S. bank said it miscalculated certain key regulatory capital ratios and will have to suspend its 2014 capital actions. 

Coca-Cola shares climbed on Tuesday after the blue-chip beverage maker posted better-than-expected quarterly sales.

Citigroup shares climbed Monday after the No. 3 U.S. bank posted better-than-expected quarterly results. 

JPMorgan Chase shares came under pressure on Friday after the biggest U.S. bank by assets posted disappointing quarterly results.

Alcoa share rose after the aluminum maker posted better-than-expected quarterly profits. 

Wyndham Worldwide shares will be in focus on Tuesday after a court said the FTC can continue with its cyber-breach case against the hotel chain.

MannKind shares plummeted in the pre-market after the FDA said it would delay its review of a key diabetes drug. 

Mylan shares rose on Friday amid hopes it could merge with Sweden-based Meda. 

General Motors and other big automakers were in focus on Tuesday. 

BlackBerry shares shot higher Friday after the smartphone maker posted a shallower-than-expected quarterly loss.

The maker of Candy Crush is set to make its public debut on the NYSE on Wednesday. 

Homebuilders will be in focus on Tuesday in the face of several key housing reports.

Nu Skin shares rallied after China hit the company with lighter-than-feared fines.

Goldman Sachs told clients to buy United Tech in favor of Boeing. 

Glaxo shares dipped on disappointing results from a cancer vaccine trial. Meanwhile, Synta Pharmaceuticals spiked on positive results in a trial for a breast cancer drug.

Oracle shares fell Wednesday after the business software giant posted disappointing quarterly results.